During a Scientific Sessions symposium jointly sponsored by the ADA and the American Society of Nephrology, four experts examined the role precision medicine trials might play in diabetic kidney disease research. “The challenge is how to distinguish patients based on their molecular mechanisms,” said Wenjun Ju, PhD.

During a unique, two-hour Current Issues presentation Tuesday morning, three experts will debate whether microvascular and macrovascular complications of diabetes are distinct pathophysiologic entities. Deborah J. Wexler, MD, MSc, will present an endocrinologist’s perspective and Jasper Tromp, MD, PhD, will offer a cardiologist’s perspective.

Three researchers from Type 1 Diabetes TrialNet—Diane K. Wherrett, MD, FRCPC, S. Alice Long, PhD, and Laura M. Jacobsen, MD—will review the latest research on immune therapy for type 1 diabetes during a two-hour virtual symposium Tuesday morning. TrialNet is an international network of academic institutions, endocrinologists, physicians, scientists, and health care teams dedicated to…

Mounting evidence indicates that sleep loss or insufficient sleep may have ramifications for the diabetes community—affecting patients whether they have type 1, type 2, or are at risk for developing diabetes. Five investigators, including Sarah S. Jaser, PhD, Erin C. Hanlon, PhD, and Susana R. Patton, PhD, will review the latest sleep science and its…

Robert H. Eckel, MD, ADA President, Medicine & Science, worked with a colleague to design a training program for a new medical subspecialty to address the growing prevalence of obesity, metabolic syndrome, and type 2 diabetes. The program draws on components of preventive cardiology, metabolic aspects of endocrinology, hepatology, nephrology, and lifestyle and obesity medicine.

From working to unravel the mysteries of insulin resistance to exploring the beneficial impact of bariatric surgery, and much more in between, Ele Ferrannini, MD, has made seminal contributions to the understanding of the pathogenesis of type 2 diabetes and its related comorbidities. For his many contributions, Dr. Ferrannini was awarded the 2020 Banting Medal…

Elizabeth Selvin, PhD, MPH, the 2020 recipient of the Kelly West Award for Outstanding Achievement in Epidemiology, reviewed highlights from decades of epidemiological evidence supporting the use of A1C for the management and diagnosis of diabetes during her Scientific Sessions award lecture. She also addressed recent controversies and criticism of the biomarker’s limitations.

During a unique symposium Monday afternoon chaired by Yehuda Handelsman, MD, four experts will be put on the spot when they’re asked to pick the best medication to prevent a cardiovascular event in a type 2 diabetes patient with established heart disease or at high risk for heart disease. Each panelist can advocate for only…

During a Monday afternoon symposium, three experts will examine the potential for extending the time between insulin injections, analyzing the need for, the feasibility of, and the clinical aspects of weekly basal insulin analogs. J. Hans DeVries, MD, PhD, and Stefano Del Prato, MD, are among the panelists who will consider whether weekly basal insulin…

Three distinguished presenters reviewed some of the most significant advances in diabetes during the Year in Review symposium, one of the most popular presentations each year at the Scientific Sessions. Alan Saltiel, PhD, reviewed basic science highlights while Lora K. Heisler, PhD, focused on translational science and David M. Nathan, MD, revisited clinical science highlights…